Main Page Aims and Scope Editorial Board Instructions to Authors Contact

 
Therapeutic options for bronchiolitis obliterans syndrome after lung transplantation [Eurasian J Pulmonol]
Eurasian J Pulmonol. 2016; 18(2): 63-69 | DOI: 10.5152/ejp.2016.92486  

Therapeutic options for bronchiolitis obliterans syndrome after lung transplantation

Nina Hangartner, Macé Matthew Schuurmans, Christian Murer, Christian Benden, Lars Christian Huber
Division of Pulmonology, University Hospital Zurich, Zurich, Switzerland

The development of chronic lung allograft dysfunction (CLAD) is one of the major obstacles following lung transplantation and limits patients’ long-term outcome. Within the group of emerging CLAD phenotypes, bronchiolitis obliterans syndrome is the most common form and observed in up to 75% of lung transplant recipients 10 years after transplantation. Therapeutic options to address BOS are limited and, at our center, include modification of immunosuppression, immunomodulation using macrolide antibiotics, the use of statins, leukotriene receptor antagonists, and extracorporeal photopheresis. The evidence for most of these therapy options is derived from case reports or small, descriptive studies, whereas controlled trials are yet to be conducted. In the context of an illustrative case report, we review hereby the current literature regarding these different treatment options.

Keywords: Bronchiolitis obliterans syndrome, chronic allograft dysfunction, lung transplantation, treatment


Nina Hangartner, Macé Matthew Schuurmans, Christian Murer, Christian Benden, Lars Christian Huber. Therapeutic options for bronchiolitis obliterans syndrome after lung transplantation. Eurasian J Pulmonol. 2016; 18(2): 63-69

Corresponding Author: Lars Christian Huber, Switzerland


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 
Quick Search




 




















 
Copyright © 2024 Turkish Respiratory Society. All rights reserved
Bu web sitesi sağlık profesyonellerine yöneliktir. İçeriğindeki yazılar ve dökümanlar hekim veya eczacı görüşü yerine geçmez. Sitenin kullanımıyla ilgili her türlü sorumluluk kullanıcıya/ziyaretçiye aittir.

LookUs & Online Makale